| A phase II trial evaluating the clinical and immunologic response of HLA-A2+ non-small cell lung cancer patients vaccinated with an hTERT cryptic peptide A Kotsakis, E Papadimitraki, EK Vetsika, D Aggouraki, EK Dermitzaki, ... Lung cancer 86 (1), 59-66, 2014 | 64 | 2014 |
| Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer I Messaritakis, E Politaki, A Kotsakis, EK Dermitzaki, F Koinis, ... PLoS One 12 (7), e0181211, 2017 | 35 | 2017 |
| TTF-1-and/or CD56-positive Circulating Tumor Cells in patients with small cell lung cancer (SCLC) I Messaritakis, D Stoltidis, A Kotsakis, EK Dermitzaki, F Koinis, ... Scientific reports 7 (1), 45351, 2017 | 28 | 2017 |
| A multicentre phase II trial of cabazitaxel in patients with advanced non-small-cell lung cancer progressing after docetaxel-based chemotherapy A Kotsakis, A Matikas, F Koinis, N Kentepozidis, II Varthalitis, ... British journal of cancer 115 (7), 784-788, 2016 | 26 | 2016 |
| The P274S mutation of lecithin-cholesterol acyltransferase (LCAT) and its clinical manifestations in a large kindred N Fountoulakis, E Lioudaki, D Lygerou, EK Dermitzaki, I Papakitsou, ... American Journal of Kidney Diseases 74 (4), 510-522, 2019 | 15 | 2019 |
| Dynamic changes of phenotypically different circulating tumor cells sub-populations in patients with recurrent/refractory small cell lung cancer treated with pazopanib I Messaritakis, E Politaki, F Koinis, D Stoltidis, S Apostolaki, M Plataki, ... Scientific Reports 8 (1), 2238, 2018 | 15 | 2018 |
| Renal artery stenting for atherosclerotic renal artery stenosis identified in patients with coronary artery disease: Does captopril renal scintigraphy predict outcomes? S Stratigis, K Stylianou, PP Kyriazis, EK Dermitzaki, D Lygerou, ... The Journal of Clinical Hypertension 20 (2), 373-381, 2018 | 12 | 2018 |
| Prognostic value of chemotherapy-resistant CK19mRNA-positive circulating tumor cells in patients with advanced/metastatic non-small cell lung cancer G Milaki, I Messaritakis, F Koinis, A Kotsakis, S Apostolaki, EK Dermitzaki, ... Cancer Chemotherapy and Pharmacology 80, 101-108, 2017 | 12 | 2017 |
| The association between handgrip strength and predialysis serum sodium level in patients with chronic kidney disease stage 5D A Markaki, P Kyriazis, EK Dermitzaki, S Maragou, E Psylinakis, ... Frontiers in Medicine 7, 610659, 2021 | 8 | 2021 |
| The p. Pro482Ala variant in the CNNM2 gene causes severe hypomagnesemia amenable to treatment with spironolactone I Petrakis, E Drosataki, I Stavrakaki, K Dermitzaki, D Lygerou, M Konidaki, ... International Journal of Molecular Sciences 23 (13), 7284, 2022 | 4 | 2022 |
| SP386 MEDITERRANEAN DIET AND MORTALITY ΙΝ CHRONIC KIDNEY DISEASE (CKD) STAGE 5D (DIALYSIS) PATIENTS IE Giannikouris, A Georgoulidou, E Dermitzaki, A Korovesi, A Kokkalis, ... Nephrology Dialysis Transplantation 34 (Supplement_1), gfz103. SP386, 2019 | 4 | 2019 |
| Long-term clinical benefit from salvage EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer patients with EGFR wild-type tumors F Koinis, A Voutsina, A Kalikaki, A Koutsopoulos, E Lagoudaki, ... Clinical and Translational Oncology 20, 140-149, 2018 | 4 | 2018 |
| Pazopanib as second line treatment of platinum sensitive SCLC patients: a multicenter phase II trial of the Hellenic Oncology Research Group A Kotsakis, V Karavasilis, S Agelaki, N Kentepozidis, S Peroukidis, ... JOURNAL OF THORACIC ONCOLOGY 10 (9), S401-S401, 2015 | 4 | 2015 |
| PLA2R-negative membranous nephropathy presenting as a prodrome of IgG4-related autoimmune pancreatitis M Velegraki, KG Stylianou, D Xydakis, H Gakiopoulou, E Voudoukis, ... Case Reports in Nephrology and Dialysis 9 (2), 85-91, 2019 | 3 | 2019 |
| Dent-2 disease with a Bartter-like phenotype caused by the Asp631Glu mutation in the OCRL gene E Drosataki, S Maragkou, K Dermitzaki, I Stavrakaki, D Lygerou, ... BMC nephrology 23 (1), 182, 2022 | 2 | 2022 |
| Salvage treatment of relapsed/refractory small cell lung cancer with pazopanib: A Hellenic Oncology Research Group’s (HORG) phase II study. A Kotsakis, V Karavasilis, S Agelaki, NK Kentepozidis, S Peroukidis, ... Journal of Clinical Oncology 34 (15_suppl), 8561-8561, 2016 | 2 | 2016 |
| Tubulointerstitial Nephritis and Uveitis Syndrome: A Report of 6 Cases with Renal Biopsy and Electron Microscopy Evaluation K Palamaris, K Stylianou, M Destouni, A Stofas, H Theodoropoulou, ... Nephron 148 (4), 204-214, 2024 | 1 | 2024 |
| Cardiorenal Syndrome: Challenges in Everyday Clinical Practice and Key Points towards a Better Management T Georgopoulou, I Petrakis, K Dermitzaki, C Pleros, E Drosataki, G Aletras, ... Journal of Clinical Medicine 12 (12), 4121, 2023 | 1 | 2023 |
| Renal Involvement of Sarcoidosis: Case Series and Review of the Literature D Lygerou, M Bolaki, K Stylianou, G Margaritopoulos, EK Dermitzaki, ... Archives of Clinical and Medical Case Reports 3 (6), 550-559, 2019 | 1 | 2019 |
| SP542 Lower Serum Magnesium (Smg) is A Strong Predictor of Left Ventricular Hypertrophy (Lvh) and Patterns of Lv Remodeling in Patients With Stage 5 Chronic Kidney Disease (Ckd) EK Dermitzaki, I Giannikouris, A Stavroulopoulos, D Hatzidimitriou, ... Nephrology Dialysis Transplantation 33 (suppl_1), i531-i531, 2018 | 1 | 2018 |
Kostas StylianouUniversity Hospital of HeraklionVerified email at uoc.gr
